Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
NRX Pharmaceuticals, Inc. | General Counsel & Secretary | Common Stock | 31.6K | $10.1K | $0.32 | Sep 2, 2021 | Direct |
NRX Pharmaceuticals, Inc. | General Counsel & Secretary | Employee Stock Option (Right to buy) | 28.9K | $5.79K | $0.20 | Sep 2, 2021 | Direct |
NRX Pharmaceuticals, Inc. | General Counsel & Secretary | Restricted Stock Units | 33.6K | Sep 2, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
NRXP | NRX Pharmaceuticals, Inc. | Aug 19, 2021 | 10 | -$545K | 4 | Nov 2, 2021 | General Counsel & Secretary |
NRXP | NRX Pharmaceuticals, Inc. | May 24, 2021 | 4 | $0 | 4 | Jun 10, 2021 | General Counsel & Secretary |
NRXP | NRX Pharmaceuticals, Inc. | May 24, 2021 | 0 | $0 | 3 | Jun 10, 2021 | General Counsel & Secretary |